Skip to main content
. 2020 Apr 9;5(7):e131486. doi: 10.1172/jci.insight.131486

Figure 3. NFATC4 expression correlates with worse ovarian cancer patient outcomes.

Figure 3

Kaplan-Meier survival plots displaying overall survival (OS), progression-free survival (PFS), and postprogression survival (PPS) of TCGA HGSC patients expressing (A) high or low NFATC4 (B) high and low RCAN1. *P < 0.05; **P < 0.01; ****P < 0.0001.